Bacillus Cereus Infection Clinical Trial
— BACILLUSOfficial title:
Contamination of Bacillus Species Sepsis.
NCT number | NCT03377530 |
Other study ID # | CHRD1715 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2008 |
Est. completion date | August 31, 2016 |
Verified date | July 2019 |
Source | Centre Hospitalier René Dubos |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Bacillus species are ubiquitous gram-positive spore-forming organisms. They rarely cause
disease in the immunocompetent and are more frequently isolated as a culture contaminant.
However, Bacillus Species can cause severe systemic infections in immunocompromised patients
including preterm infants.
The purpose of this study is to identify the risk factors of these infections.
Status | Completed |
Enrollment | 11 |
Est. completion date | August 31, 2016 |
Est. primary completion date | August 31, 2016 |
Accepts healthy volunteers | |
Gender | All |
Age group | N/A to 28 Days |
Eligibility |
Inclusion Criteria: - cases of Bacillus Species sepsis - cases of Bacillus species meningitis - with significant change in clinical status - Bacillus Species is the only organism isolated Exclusion Criteria: - Bacillus Species isolated with other organisms and Bacillus Species without clinical change were considered to be contaminants |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier René Dubos |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Severe infection rate due to Bacillus Sp germ | The purpose of this database is to mesure the pathogenicity of this germ based on the severe infection rate | Through study completion, an average of 1 year. | |
Secondary | To collecte the incriminated modes of contamination. | The purpose of this database is to describe the incriminated modes of contamination. | Through study completion, an average of 1 year. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06328634 -
Bacillus Cereus Infection of Patients Diagnosed at Nîmes University Hospital
|